What You Should Know:
– Nebraska Medicine, the clinical partner of the University of Nebraska Medical Center, achieved a nearly 6x increase in lung cancer risk assessment completion through a collaboration with CancerIQ, a best-in-class cancer-focused…
Continue Reading
Siemens Healthineers has received FDA Premarket Approval (PMA) for its cutting-edge Mammomat B.brilliant mammography system. This innovative system integrates new 3D image acquisition and reconstruction technology, setting a new standard for breast cancer screening….
Continue Reading
Henley Business School has been awarded a grant of £1.2 million for the development of a machine learning system to improve the early detection and referral of rheumatic and musculoskeletal diseases (RMD).
A pilot of…
What You Should Know:
Cognoa, a leading child development and behavioral health company, today announced its inclusion as a covered benefit under Wyoming Medicaid that will cover the cost of the company’s flagship product, Canvas…
Continue Reading
AI-Powered Chest X-rays Enhance Rapid Lung Cancer Diagnosis
Artificial intelligence (AI) continues to transform healthcare, with new innovations enhancing diagnostic capabilities. A recent study presented at the 2024 World Conference on Lung Cancer by the…
What You Should Know:
– A new study presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer offers exciting possibilities for early lung cancer detection.
– Researchers…
Continue Reading
What You Should Know:
– A recent survey by the Prevent Cancer Foundation reveals a concerning trend among Gen Z (ages 21-27) – they are significantly lagging behind older generations in getting routine cancer screenings.
–…
Continue Reading
Introduction
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, primarily due to the challenges in early detection and monitoring. However, the recent advancements in artificial intelligence (AI) are revolutionizing lung cancer…
Diabetic macular edema (DME) has emerged as the foremost cause of vision loss in the population with diabetes. Early detection of DME is paramount, yet the prevailing screening, relying on two-dimensional and labor-intensive fundus…
Continue Reading
What You Should Know:
– The American Cancer Society (ACS) and Color Health have joined forces to launch a new pilot program aimed at increasing access to colorectal cancer screening in underserved communities.
– The program,…
Continue Reading
